Bio-Rad Laboratories (BIO) Gross Profit (2009 - 2026)
Bio-Rad Laboratories (BIO) posted quarterly Gross Profit of $309.4 million for Q1 2026, up 1.11% year-over-year from $306.0 million in Q1 2025, and down 10.37% quarter-over-quarter from $345.2 million in Q4 2025.
Bio-Rad Laboratories (BIO) Gross Profit (2009 - 2026) Analysis & Trends
Bio-Rad Laboratories (BIO) has reported Gross Profit for 18 consecutive years, with $309.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Gross Profit rose 1.11% year-over-year to $309.4 million; the TTM figure through Mar 2026 stood at $1.3 billion (down 1.16% YoY), while the FY2025 annual figure was $1.3 billion, down 2.83% from the prior year.
- Gross Profit declined to $309.4 million in Q1 2026 per BIO's latest filing, from $345.2 million in the prior quarter.
- Across five years, Gross Profit topped out at $402.6 million in Q1 2022 and bottomed at $306.0 million in Q1 2025.
- Historically, Gross Profit has averaged $354.3 million across 5 years, with a median of $355.1 million in 2024.
- Annual changes were most pronounced in 2022 — Gross Profit fell 14.64% — and 2024, when it advanced 6.02%.
- Bio-Rad Laboratories' Gross Profit stood at $397.1 million in 2022, then fell by 7.76% to $366.3 million in 2023, then decreased by 6.63% to $342.0 million in 2024, then climbed by 0.94% to $345.2 million in 2025, then decreased by 10.37% to $309.4 million in 2026.
- Business Quant data shows BIO's Gross Profit at $309.4 million in Q1 2026, $345.2 million in Q4 2025, and $343.4 million in Q3 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|